Atlas Trials

Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

Clinical trial NCT02008461 · UNKNOWN

Trial details

NCT number
NCT02008461
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Supra-ventricular Tachyarrhythmias
Start date
2013-06-01
Primary completion
2015-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.